An Alternative Perspective towards Reducing the Risk of Engineered Nanomaterials to Human Health

Abstract

To elucidate the impact of human exposure to engineered nanomaterials, advanced in vitro models are a valid non‐animal alternative. Despite significant gains over the last decade, implementation of these approaches remains limited. This work discusses the current state‐of‐the‐art and how future developments can lead to advanced in vitro models better supporting nano‐hazard assessment.